Dominion Aesthetic Technologies Inc reported on Tuesday the receipt of US FDA clearance for its medical, non-contact body contouring product, eon FR.
The company added that the eon FR is capable of reducing fat over a larger surface area than its competitors, which is highly desired by both physicians and patients. The body shaping technology delivers non-contact, laser energy to reduce fat in the abdomen using a patent-pending powered articulated arm.
According to the company, the eon FR causes the death of fat cells through apoptosis process that takes from six to 12 weeks and after the eon FR body contouring treatment, the body naturally eliminates fat cells through its lymphatic system. The treatment takes about 15 minutes to perform with no downtime.
Headquartered in San Antonio, TX, the laser-based medical device company offers the best innovative tools to serve the physicians' practices and the patients' needs.
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
Sensiva Health names new chief operating officer
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
Amphix Bio announces initial closing of USD12.5m seed financing round
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system
Bonesupport shifts CERAMENT V review to FDA's De Novo pathway
Neola Medical secures US patent for disposable lung monitoring probes